Article
How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma
23 Apr 2021
Abstract excerpt
Uveal melanoma (UM), though a rare form of melanoma, is the most common intraocular tumor in adults. Conventional therapies of primary tumors lead to an excellent local control, but 50% of patients develop metastases, in most cases with lethal outcome. Somatic driver mutations that act on the MAP-kinase pathway have been identified, yet targeted therapies show little efficacy in the clinics. No drugs are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
